S
4.30
0.28 (6.97%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Sana Biotechnology, Inc. | 看跌 | 混合的 |
AIStockmoo 评分
-1.1
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -1.13 |
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 8.46% |
| 机构持股比例 | 89.37% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Integral Health Asset Management, Llc | 30 Sep 2025 | 2,000,000 |
| Crestline Management, Lp | 30 Sep 2025 | 1,820,937 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 9.00 (HC Wainwright & Co., 109.30%) | 购买 |
| 中 | 8.00 (86.05%) | |
| 低 | 6.00 (Wedbush, 39.54%) | 购买 |
| 平均值 | 7.67 (78.37%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 4.36 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Nov 2025 | 9.00 (109.30%) | 购买 | 4.09 |
| Wedbush | 07 Nov 2025 | 6.00 (39.53%) | 购买 | 4.09 |
| 24 Sep 2025 | 5.00 (16.28%) | 购买 | 3.41 | |
| Citizens | 30 Oct 2025 | 8.00 (86.05%) | 购买 | 4.90 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合